Loading


Notice Concerning Completion of Acquisition Company's Own Shares Through ToSTNet-2



The Company's Official Page
http://www.torii.co.jp/en/ir/releases/20031111.html
Back To Previous Page

Site Map | Changes / Renewal | Terms of Use
back

November 11, 2003
Torii Pharmaceutical Co., Ltd.
Notice Concerning Completion of Acquisition Company's Own Shares
Through ToSTNet-2
Torii Pharmaceutical Co., Ltd. announced the acquisition of its own shares made in accordance with the announcement of November 10, 2003. The transaction took place today as detailed below.

1.Type of shares acquired: common stock
2.Total number of shares acquired: 486,000 shares
3.Purchase price: ¥1,718 per share
4.Total value of acquisition: ¥834,948,000
5.Acquisition date: November 11, 2003
6.Method of purchase : Through ToSTNet-2 (closing price transaction) of the Tokyo Stock Exchange

(Reference)
(1) Resolution at the ordinary general meeting of shareholders held on June 24, 2003
Type of shares to be acquired:
Total number of shares to be acquired:
Total value of shares acquired:
common stock
1,000,000 shares (maximum)
¥1,800,000,000 (maximum)
(2) Progress as of November 11, 2003
Total number of shares acquired:
Total value of acquisition :
486,000 shares
¥834,948,000


back



Related Latest News
"Torii Pharmaceutical Co., Ltd." more
"Pharmaceuticals" Listed Companies more
"Pharmaceuticals" Non-listed Companies more
"Tokyo" Companies more

WARNING: (1) Because this website uses a computer program to automatically collect and display press-release text information, errors or inaccuracy may occur. Double-check with information on these companies' official websites. (2) A press release may contain facts, figures and preliminary forward-looking statements which are subject to change.
Latest Press Release Search


Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.